Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Major innovation in fight against pleural cancer

05 Apr 2016 | Health Nutrition, A region on the move

Lille hospital plays a key role in new treatment for pleural cancer.

For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

Back to news

News

GSK creates 100 new jobs in Hauts-de-France

In response to the growing demand for vaccines, GSK’s plant at Saint-Amand-les-Eaux has launched two recruitment drives to fill100 new jobs.

Amazon: 6 sites in Hauts-de-France

In November, Amazon will open a brand new delivery centre in Avion. This is the American giant’s 6th site in the region, once more confirming the attractiveness of Hauts-de-France for logistics.

All news